After you have read Arbisi and Farmer's reviews of the Beck Depression Inventory-II, compare how Arbisi and Farmer discuss the applicability of the BDI-II to specific populations. What weaknesses are revealed about the development of the test? To what degree do these issues warrant cautions regarding the use of the BDI-II with diverse populations? Refer to the ACA Code of Ethics in your response.
Note: See attachment -Farmer's review is underneath Arbisi's review on the same page.
This solution comapres views on the Beck Depression-II Inventory.